Bifogade filer
Respiratorius - Minimal activity, case intact
Prenumeration
Du har en aktiv prenumeration.
Prenumerera på pressmeddelanden från Redeye via email.
Du prenumererar på följande språk.
Välj vilka språk du vill prenumerera på.
Modular Finance AB kommer att hantera vissa av dina personuppgifter om du väljer att prenumerera. Mer information om vår personuppgiftshantering finns här.
2024-02-14 08:01:00
Redeye finetunes its estimates following the Q4 2023 report from Respiratorius. The company is waiting for a licensing partner to take its lead candidate VAL-001 through phase III. The cash position was SEK1.9m at the end of Q4, with free cash flow of SEK-0.9m for the quarter. Until a licensing deal is announced, the cash burn is expected to remain minimal.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/